Evaluation of discharge patients with T2DM based on target goals of therapy at a private hospital in sana,a, Yemen

Abstract

Objective : The management of type 2 diabetes mellitus (T2DM) is complex , requiring continuous medical care by health care professionals and considerable self-care efforts by patients. Clinical pharmacy have important role in team of health care in management the therapy, reinforce patient education, resolution of drug-related problems(DRPs), This study also aims to draw attention to important clinical pharmacy in periodically evaluation for medication problems of discharge patient with T2DM.

Methods: The study was a clinical retrospective study performed on discharge patient with T2DM in private Hospital in Sana'a city between December 4,2021 and January 4,2022.

Results: A total of 150 diagnosed cases of T2DM were studied . Male patients were 87 (58.0%) and female patients were 63 (42.0%) . The age of patients with T2DM ranged between 20 and 82 years . The results of the patient study showed that most patients with T2DM aged above 41 years (92.0%). The patient lipid profile labs were categorized into three category : normal 29 (19.3%) ,abnormal 51(34.0%) and non-available 70(46.7%). The fasting blood glucose (FBG) range were minimum range

were ( 75 mg / dl). And maximum range were (622 mg /dl).

HBA1C labs minimum range were ( 5.7 mmol / L). And maximum range were ( 14.5 mmol / L). The most patients of T2DM were without comorbidity 77(51.3%), 56(37.3%) with hypertension and 15(10%) with cardiovascular disease. Almost patients of T2DM were without major drug-drug interaction 145(96.7%) . According to ADA 2022 guideline  47 (31.3%) of patients of T2DM were acceptable, most

percent 74(49.3%) without statin recommendation and less percent 12(8%) without ACEI and 14(9.3%) without ACEI and statin .

Conclusions:

According to the results of this study the clinical outcomes of discharge patient of T2DM not acceptable to some extent according to the recommendation of ADA guideline , so activate the role of clinical pharmacy improvement from clinical outcomes for patients.